Concepedia
Statistics
Publications
14
Citations
2.4K
H-Index
Active since
2009
Affiliations
Peter MacCallum Cancer Centre(Current)
The University of Melbourne
Monash University
The University of Queensland
QIMR Berghofer Medical Research Institute
Liza B. John is an author at Peter MacCallum Cancer Centre specializing in medicine, immunology, and immunotherapy.
Top concepts
MedicineImmunologyImmunotherapyTumor MicroenvironmentCell BiologyImmunomodulationRadiation OncologyImmune Cell TherapyAutoimmunityTumor Biology
Publications per year
2009–2018
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
Liza B. John, Christel Devaud, Connie P.M. Duong et al. · Clinical Cancer Research · 2013 · 688 citations
Blockade of A <sub>2A</sub> receptors potently suppresses the metastasis of CD73 <sup>+</sup> tumors
Paul A. Beavis, Upulie Divisekera, Christophe Paget et al. · Proceedings of the National Academy of Sciences · 2013 · 334 citations · Full text
Immunology, Immune Regulation, Immunoediting +16
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses
Paul A. Beavis, Nicole Milenkovski, Melissa A. Henderson et al. · Cancer Immunology Research · 2015 · 314 citations
Immunology, Immune Regulation, Immunoediting +18
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
Paul A. Beavis, Melissa A. Henderson, Lauren Giuffrida et al. · Journal of Clinical Investigation · 2017 · 309 citations · Full text
Chimeric Antigen Receptor, Cancer Immunosurveillance, Signal Transduction +15
Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
Liza B. John, Michael H. Kershaw, Phillip K. Darcy · OncoImmunology · 2013 · 132 citations · Full text
Chimeric Antigen Receptor, Radiation Oncology, Tumor Eradication +13
1–5 of 14